These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 31471148

  • 1. A comparative study of the effect of UV and formalin inactivation on the stability and immunogenicity of a Coxsackievirus B1 vaccine.
    Hankaniemi MM, Stone VM, Sioofy-Khojine AB, Heinimäki S, Marjomäki V, Hyöty H, Blazevic V, Laitinen OH, Flodström-Tullberg M, Hytönen VP.
    Vaccine; 2019 Sep 20; 37(40):5962-5971. PubMed ID: 31471148
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Optimized production and purification of Coxsackievirus B1 vaccine and its preclinical evaluation in a mouse model.
    Hankaniemi MM, Laitinen OH, Stone VM, Sioofy-Khojine A, Määttä JAE, Larsson PG, Marjomäki V, Hyöty H, Flodström-Tullberg M, Hytönen VP.
    Vaccine; 2017 Jun 27; 35(30):3718-3725. PubMed ID: 28579231
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Coxsackievirus B Vaccines Prevent Infection-Accelerated Diabetes in NOD Mice and Have No Disease-Inducing Effect.
    Stone VM, Butrym M, Hankaniemi MM, Sioofy-Khojine AB, Hytönen VP, Hyöty H, Flodström-Tullberg M.
    Diabetes; 2021 Dec 27; 70(12):2871-2878. PubMed ID: 34497136
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes.
    Stone VM, Hankaniemi MM, Svedin E, Sioofy-Khojine A, Oikarinen S, Hyöty H, Laitinen OH, Hytönen VP, Flodström-Tullberg M.
    Diabetologia; 2018 Feb 27; 61(2):476-481. PubMed ID: 29151123
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [A bivalent VP1 gene vaccine against Coxsackie virus B1/B3].
    Wu X, Zhao T, Tian Y.
    Zhonghua Yi Xue Za Zhi; 2001 Apr 25; 81(8):480-4. PubMed ID: 11798923
    [Abstract] [Full Text] [Related]

  • 12. Development of an experimental inactivated vaccine from Vero cell adapted Enterovirus D68.
    Raychoudhuri A, Naru AK, Kanubothula SR, Uddala R.
    Virus Res; 2021 Oct 15; 304():198528. PubMed ID: 34339771
    [Abstract] [Full Text] [Related]

  • 13. Occurrence of coxsackievirus hepatitis in baby rabbits and protection by a formalin-inactivated polyvalent vaccine.
    See DM, Tilles JG.
    Proc Soc Exp Biol Med; 1997 Oct 15; 216(1):52-6. PubMed ID: 9316610
    [Abstract] [Full Text] [Related]

  • 14. Comparison of structure and immunogenicity of CVB1-VLP and inactivated CVB1 vaccine candidates.
    Soppela S, Plavec Z, Gröhn S, Jartti M, Oikarinen S, Laajala M, Marjomaki V, Butcher SJ, Hankaniemi MM.
    Res Sq; 2024 Jun 28. PubMed ID: 38978565
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of a polyvalent inactivated-virus vaccine in protecting mice from infection with clinical strains of group B coxsackieviruses.
    See DM, Tilles JG.
    Scand J Infect Dis; 1994 Jun 28; 26(6):739-47. PubMed ID: 7747099
    [Abstract] [Full Text] [Related]

  • 16. Single B cells reveal the antibody responses of rhesus macaques immunized with an inactivated enterovirus D68 vaccine.
    Zheng H, Yang Z, Li B, Li H, Guo L, Song J, Hou D, Li N, Yang J, Wu Q, Sun M, Liu L.
    Arch Virol; 2020 Aug 28; 165(8):1777-1789. PubMed ID: 32462286
    [Abstract] [Full Text] [Related]

  • 17. The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease.
    Lim H, In HJ, Lee JA, Sik Yoo J, Lee SW, Chung GT, Choi YK, Chung JK, Cho SJ, Lee JW.
    Vaccine; 2018 Jun 07; 36(24):3445-3452. PubMed ID: 29739716
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses.
    Cai Y, Ku Z, Liu Q, Leng Q, Huang Z.
    Vaccine; 2014 May 01; 32(21):2406-12. PubMed ID: 24657161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.